ESHAP regimen

Known as: Etoposide-Solumedrol-High Dose Ara-C, Platinol Regimen 
A regimen consisting of etoposide, methylprednisolone, high-dose cytarabine and cisplatin, used to treat relapsed and refractory Hodgkin's and non… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1990-2017
02419902017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
BACKGROUND Despite multiple published studies reporting result of salvage regimens for relapsed and refractory Hodgkin's lymphoma… (More)
Is this relevant?
2010
2010
BACKGROUND High-dose chemotherapy (HDT) followed by autologous stem-cell transplantation (ASCT) is considered the gold standard… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2008
Highly Cited
2008
AIM To analyze toxicity, response and outcome of a phase II trial with intensive chemotherapy plus autologous stem-cell… (More)
  • table 1
  • table 2
  • figure 2
  • figure 3
  • table 3
Is this relevant?
2008
2008
We describe the rare case of a 53-year-old woman with systemic involvement of Langerhans cell sarcoma (LCS) who had undergone… (More)
Is this relevant?
2007
2007
BACKGROUND It has previously been shown that ESHAP was an effective mobilization regimen for patients with pretreated lymphoma… (More)
Is this relevant?
2006
2006
BACKGROUND The ESHAP chemotherapy regimen, that is, the combination of the etoposide, methylprednisolone, high-dose cytarabine… (More)
  • table 1
  • table 3
  • table 2
  • figure 1
  • figure 2
Is this relevant?
2002
2002
The ESHAP regimen, a combination of the chemotherapeutic drugs etoposide, methylprednisolone (solumedrol), high-dose cytarabine… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
1999
1999
BACKGROUND The ESHAP regimen, a combination of the chemotherapeutic drugs etoposide, methylprednisolone (solumedrol), high-dose… (More)
Is this relevant?
1998
1998
High-dose therapy with peripheral blood stem cell (PBSC) support is a frequently used treatment option in younger patients with… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
Highly Cited
1994
Highly Cited
1994
PURPOSE This study attempted to determine the efficacy of the combination of etoposide (VP-16), methyl-prednisolone, and… (More)
Is this relevant?